Skip to main content

Table 3 Non-hematologic toxicities

From: Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia

Toxicity

Grade 3, N (%)

Grade 4, N (%)

Grade 5, N (%)

Infections-related and unrelated

49 (45)

17 (15)

7 (6)

Hyperglycemia

21 (19)

4 (4)

0

Pain (back, bone, abdominal, joint, muscle)

19 (17)

0

0

Hemorrhage

14 (13)

1 (1)

2 (2)

Increased liver function tests

13 (12)

2 (2)

0

Hypokalemia

11 (10)

4 (4)

0

Increased bilirubin

10 (9)

2 (2)

0

Cardiac

10 (9)

0

1 (1)

Neurotoxicities

9 (8)

2 (2)

0

Headache

9 (8)

0

0

Fatigue

5 (5)

0

0

Constipation

5 (5)

0

0

Mucositis

5 (5)

0

0

Hepatic sinusoidal obstruction syndrome

2 (2)

0

2 (2) (1 pre SCT, 1 post SCT)

Nausea

3 (3)

1 (1)

0

Hyponatremia

2 (2)

1 (1)

0

Thrombosis

3 (3)

0

0

Generalized muscle weakness

3 (3)

0

0

Hypoalbuminemia

3 (3)

0

0

Hypophosphatemia

3 (3)

0

0

Diarrhea

2 (2)

0

0

Neuropathy

2 (2)

0

0

Pancreatitis

2 (2)

0

0

Acute kidney injury

2 (2)

0

0

Hypercalcemia

2 (2)

0

0

Hypocalcemia

2 (2)

0

0

  1. SCT Allogeneic stem cell transplantation